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Background: Besides the defining involvement of upper and lower motor neurons, the involvement of extramotor
structures has been increasingly acknowledged in amyotrophic lateral sclerosis (ALS).
Methods: Here we investigated a group of 14 mildly to moderately affected ALS patients and 14 age-matched
healthy control participants using cortical thickness analysis. Cortical thickness was determined from high resolution
3D T1 magnetic resonance images and involved semiautomatic segmentation in grey and white matter, cortical
alignment and determination of thickness using the Laplace method. In addition to a whole-cortex analysis a
region of interest approach was applied.
Results: ALS patients showed regions of significant cortical thinning in the pre- and postcentral gyri bilaterally.
Further regions of cortical thinning included superior and inferior parietal lobule, angular and supramarginal gyrus,
insula, superior frontal, temporal and occipital regions, thus further substantiating extramotor involvement in ALS. A
relationship between cortical thickness of the right superior frontal cortex and clinical severity (assessed by the ALS
functional rating scale) was also demonstrated.
Conclusions: Cortical thickness is reduced in ALS not only in motor areas but in widespread non-motor cortical
areas. Cortical thickness is related to clinical severity.
Keywords: ALS, Cortical thickness, MRIBackground
Amyotrophic lateral sclerosis (ALS) is a neurodegenera-
tive disease with upper and lower motor neuron involve-
ment as its clinical hallmarks. Dating back to very early
observations that a significant percentage of ALS patients
develop a dementia it has been clear that extramotor in-
volvement can occur. That such involvement is the rule ra-
ther than the exception has been underscored by findings
from neuropsychological [1-4] and neuroimaging [5-9] in-
vestigations. The recent discovery that the C9ORF72
hexanucleotide repeat can cause both, frontotemporal de-
mentia and ALS as well as overlapping syndromes, further
underscores that the molecular underpinnings of ALS* Correspondence: Thomas.muente@neuro.uni-luebeck.de
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reproduction in any medium, provided the ormight damage extramotor and motor parts of the ner-
vous system [10]. The question therefore arises, to what
extent disturbances of non-motor functions are reflected in
changes of cortical structure. Primary motor and extramotor
involvement has been demonstrated repeatedly by voxel
based morphometry (VBM) [11-13], although other studies
did not report atrophy [14,15].
VBM is a fully automated, operator-independent tech-
nique that allows the voxel-wise comparison of segmented
grey and white matter images between two groups of sub-
jects [16-19]. As such, it has the advantages of being fast
and independent of any observer rating or a priori hypoth-
esis on the location of the structural abnormality. There
are several limitations of this approach, however [18,20].
For example, VBM simultaneously reflects size, position
and morphology. As nonlinear spatial normalization
and spatial filtering is used to accommodate anatomicalLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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important differences, in particular when these are
circumscribed. Moreover, VBM reveals differences in
grey matter density, which may not equate in a simple
way to atrophy.
In the present investigation we therefore employed an
alternative to VBM, cortical thickness analysis (CTA).
CTA is based on a semiautomatic/interactive segmenta-
tion of brain white and grey matter followed by a deter-
mination of the thickness of the cortical layer [21-24].
Thickness values are then entered into standard between
group statistics allowing a comparison for the entire cor-
tical surface. Neuropathological studies have described
atrophy involving the precentral gyrus with loss of Betz
cells and gliosis in ALS [25,26] which lead us to suspect
a decreased cortical thickness in ALS. Also, cortical
thinning of the motor cortex has been described recently in
ALS [27-30] and primary lateral sclerosis [31]. Verstraete
et al. [28,29] could demonstrate that cortical thinning in
temporal regions was related to faster clinical progression,
whereas in a recent study by Agosta et al. [30] age and cor-
tical thinning in sensorimotor cortex was related in ALS
patients but not in controls. Interestingly, no relationship
was found between clinical severity and cortical thickness.
Finally, in a recent study by Schuster et al. [32] clinical
variables were related to cortical thinning of the primary
motor cortex (PMC). Upper motor neuron (UMN) signs
in the bulbar region were associated with bilateral thin-
ning within the bulbar segment on the motor cortex,
whereas UMN signs of the extremities were associated
with thinning in the limb segment of the motor cortex.
In the present investigation, we asked specifically whether
other areas in addition to the motor cortex are affected
with regard to cortical thinning. We were further interested
in whether CTA is more sensitive to cortical changes in
ALS than VBM and performed CTA on a sample of ALS
patients and controls that has previously been reported
in a VBM study [13].
Methods
Patients
The study was approved by the ethics committee of
Hannover Medical School. All participants gave their
written informed consent prior to their inclusion in
the study.
The original patient group comprised 17 subjects
(3 women) classified as having definite, probable or
possible ALS according to the revised El Escorial criteria
[33] at the time of testing. All but one patient had
progressed to definite or probable ALS on follow up. Data
quality of the scans did not allow reliable differentiation
between grey and white matter in three patients. For the
remaining 14 patients mean (± S.D.) duration since
onset of symptoms, henceforth disease duration, was23.1 ± 7.7 months, mean age was 58.4 ± 13.1 (range 31–77)
years and duration of education in years was 12.8 ± 2.6.
Seventeen age matched healthy participants were recruited
as a control group. Of these, only those 14 participants
that most closely matched the 14 remaining patients with
regard to age (57.9 ± 11.8, p = 0.86), sex (patients: 2
women, controls: 3 women), and education (controls
11.9 ± 3.1, p = 0.79) were further analyzed. Neither patients
nor controls had a history of cerebrovascular disease,
longstanding hypertension or inflammatory disease of
the central nervous system. All patients received riluzole
treatment but no psychoactive drugs. Their score on the
revised ALS functional rating scale [34,35] (ALSFRS-R)
was 40.6 ± 4.7 points.
Clinical data
A number of clinical data were obtained to correlate these
with cortical thickness. ALSFRS-R progression rate per
month was calculated for the total disease duration [PR/
mth(t)] and the six month period prior to MRI [PR/mth
(6)]. Sum scores of Medical Research Council (MRC)
muscle strength were taken for the upper extremity
(shoulder abduction, inward and outward rotation; elbow
flexion and extension; lower arm pronation and supin-
ation; wrist flexion and extension; finger flexion, exten-
sion, abduction and adduction; 5th finger abduction
and thumb opposition; highest possible score 75 points)
and the lower extremity (hip strength; knee flexion and
extension; foot flexion, extension, inversion and eversion;
toe flexion and extension; best possible score 45 points).
Bulbar involvement was described as a sum score of dys-
arthria (0 = no, 1 = yes), dysphagia (0 = no, 1 = yes), eyelid
closure, mouth closure, tongue movement and palate
elevation (0 = normal, 1 = reduced, 2 = weak, 3 = absent)
with a lowest possible score of 14. Reflexes were summed
by counting the number of muscles scoring 3 or 4 on the
NINDS reflex scale for the biceps, triceps, brachioradialis,
finger flexor, quadriceps and gastrocnemius muscles on
both sides and masseter muscle (maximum score 13).
Spasticity was described as none (0), noticeable (1), pro-
nounced (2), barely to overcome (3) and not to overcome
(4) with a worst score of 32 (arm, hand, upper thigh, lower
thigh both sides). A positive Babinski sign was counted
separately for each side (worst score of 2). The clinical
characteristics of the patients are summarized in Table 1.
Image acquisition
Images were acquired on a neuro-optimized 1.5-T GE
Signa Horizon LX (General Electric Company, Milwaukee,
WI, USA) using a 3-dimensional T1-weighted spoiled
gradient recalled echo (SPGR) sequence generating 124
contiguous sagittal slices (RT 24 ms; TE 8 ms; flip angle
30°, 2 averages, acquisition time 13′10′, in plane resolution
0.97 × 0.97 × 1.5 mm3). During scanning, all participants
Table 1 Clinical data
















ALSFRS-R ALSFRS-R PR/M6 ALSFRS-R PR/M(t)
1 59 m 30 68 69 41 41 2 0 0 0 43 0.5 0.2
2 59 m 13 75 64 31 27 0 0 0 0 37 1.8 0.8
3 31 m 17 64 62 45 45 0 2 0 12 42 1.2 0.4
4 68 m 22 75 73 45 42 2 2 4 4 40 0.7 0.4
5 65 m 25 72 75 26 16 0 1 0 6 37 0.7 0.4
6 53 m 38 74 75 26 23 0 0 0 0 43 0.2 0.1
7 34 w 18 70 71 45 45 4 2 0 12 39 1.0 0.5
8 62 m 18 63 73 45 45 4 0 0 12 40 0.7 0.4
9 49 m 19 54 55 45 45 0 2 0 0 41 0.3 0.4
10 60 m 30 58 57 45 45 2 2 0 5 33 1.5 0.5
11 77 m 34 70 71 22 37 0 2 2 12 33 1.7 0.4
12 63 w 12 75 75 45 45 3 0 0 11 45 0.2 0.3
13 66 m 23 61 71 44 44 0 1 0 0 48 0.0 0.0
14 72 m 25 69 71 40 41 3 2 4 6 48 1.0 0.3
Pat. = patient; Dur. = duration in months; m =man, w =woman; RUE, LUE, RLE, LLE: right upper, left upper, right lower, left lower extremity; ALSFRS-R: ALS functional
rating scale- revised, PR/M6 progression rate for the 6 months prior to MR-scanning, PR/M(t) progression rate per month for the entire duration of the disease.
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within the headcoil with special cushions. All subjects
received additional T2-weighted images to exclude any
ischemic or inflammatory lesions. These were normal in
all participants.
Preprocessing and advanced segmentation analysis
The entire analysis was performed using Brainvoyager QX
1.8-1.10 (Brain Innovation, Maastricht, The Netherlands).
Data was resampled to achieve 1 × 1 × 1 mm resolution,
aligned to the AC-PC line and transformed into Talairach
standard space. Prior to cortical thickness analysis, data
had to be resampled once more to 0.5 mm iso-voxel using
sinc interpolation. The brain was then segmented from
surrounding head tissue using an automatic “brain peel-
ing” tool [36] and subcortical structures and the cerebel-
lum were removed using a mask. Tissue contrast and
homogeneity were enhanced by converting the grey-scale
from 8 bit to 16 bit resolution and by using a sigma filter.
The border between white and grey matter was segmented
automatically using an adaptive region growing step using
locally computed histograms and gradient information.
Subsequently, the border between grey matter and cere-
brospinal fluid border was segmented using a dilation
process beginning at the white matter–grey matter bound-
ary and moving towards the CSF boundary. This process
was controlled by computed gradient fields and histogram
analysis of grey matter–CSF threshold values. The afore-
mentioned segmentation steps proved to be unreliable in
several regions of the brain, leading, for example, to brid-
ges across sulci. Thus, extensive interactive correction was
carried out by author JT who was blinded with regard towhether or not a given brain belonged to a patient or a
control participant.Cortical alignment
To further improve the spatial correspondence between
participants’ brains, reconstructed cortices were aligned
using curvature information reflecting the gyral/sulcal
folding pattern. This approach has been shown to substan-
tially reduce anatomical variability [37]. The reconstructed
folded cortical representations of each participant were
morphed into a spherical representation (separately for
each hemisphere) providing a parameterizable surface
suitable for across-subject non-rigid alignment. Each ver-
tex on the sphere corresponded to a vertex of the folded
cortex. The curvature information was preserved as a
curvature map on the spherical representation and was
smoothed along the surface to provide spatially extended
gradient information for intercortex alignment. The mean
squared differences between the curvature of a source and
a target sphere were minimized during the iterative align-
ment process [36,38].
Cortical thickness maps for each subject were calculated
and measurements were performed using the Laplace
method [23] as implemented in Brain Voyager Qx. For
the whole-cortex analysis the correction for multiple com-
parisons was performed using cluster-size thresholding.
The procedure started with setting a threshold (manually)
for the map relative to the contrast of interest with a
p < 0.05 (uncorrected). Next, the intrinsic smoothness of
the resulting map was evaluated automatically [36,39].
The final result was a minimum cluster size threshold
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p value of < 0.045.Region-of-interest analysis of cortical thickness maps
While group differences in cortical thickness measure-
ments can be mapped at the vertex level, the statistical
power of this approach is limited because of the multiple
comparisons problem. We therefore also explored cortical
thickness in certain regions (or more precisely cortical
patches) of interest. We used previous functional data
and structural data to guide definition of patches of
interest which were placed in the left and right pre- and
postcentral gyri as well as in the left and right superior
frontal gyrus and the inferior frontal sulcus. The average
cortical thickness was determined for each region of
interest (ROI) and participant and results were subjected to
statistical analysis using between group t-tests or Pearson
correlation.Results
Whole cortex analysis
Results at the vertex level are shown in Figure 1 with
blue colors indicating regions with significantly reduced
cortical thickness and red regions indicating regions in
which cortical thickness was increased with regard to the
normal participants.
Table 2 illustrates the cortical regions that showed signifi-
cantly reduced cortical thickness in ALS. These included
regions in the pre- and postcentral gyrus bilaterally, the
SPL bilaterally, the insula bilaterally, the cingulate gyrus
and sulcus bilaterally and the angular/supramarginal gyri
and regions in the temporal and occipitotemporal cortex.
Thus, cortical thinning extended well beyond the sensori-
motor cortex.Figure 1 Results from the whole cortex analysis. Areas with
significant thinning in ALS are depicted blue whereas areas with
increased cortical thickness are shown in red. P1, P2, P3 refer to
patches of interest described further in Figure 2.There were few regions showing increased thickness
in ALS (see Table 3) including parts of temporal cortex
and cingulate cortex.
Region of interest analysis
Both, left and right precentral cortex showed a highly
significant reduction of the cortical thickness in ALS
(left: t(26) = 3.76, p < 0.001; right: t(26) = 3.81, p < 0.001).
The left and right postcentral gyrus again showed a
highly significant reduction of the cortical thickness
in ALS (left: t(26) = 3.24, p < 0.005; right: t(26) = 3.51,
p < 0.003). The superior frontal gyrus showed significant
thinning in ALS on the left (t(26) = 3.2, p < 0.005) and
right (t(26) = 3.8, p < 0.001). The inferior frontal sulcus
also showed significant thinning on the left (t(26) = 3.29,
p < 0.003) and right (t(26) = 2.36, p < 0.03).
To further illustrate the reduction of cortical thickness
in the pre- and postcentral gyri and the precentral sulci,
we computed cortical thickness for a number of patches
(see Figure 2 for location and Figure 3 for numerical re-
sults). Interestingly, LH3 which was located in the area
of the bulbar representations numerically showed a more
pronounced but non-significant reduction in patients with
bulbar involvement (1.7 mm compared to 2.1 mm in non-
bulbar patients).
We repeated these ROI analyses with age, sex, and disease
duration as covariate using the procedure UNIANOVA
of SPSS instead of a t-test. This did not change the pat-
tern of results.
Correlations with clinical data
Cortical thickness of the ROIs showed a correlation with
ALSFRS-R in the right superior frontal gyrus (r = −0.534,
P < 0.05, Figure 4) and the right inferior frontal gyrus
(r = −0.535; p < 0.05). Cortical thickness of the right in-
ferior frontal sulcus correlated with progression score
(r = 0.591; p < 0.03).
We did not find any systematic relationship between
cortical thickness and the scores assessing spasticity and
reflexes.
Finally, we also did not observe a correlation between
age and cortical thickness in any region.
Discussion
Expectedly, the current study revealed cortical thinning
of the primary motor cortex bilaterally in ALS. Import-
antly, atrophy was also found for the postcentral gyrus
bilaterally demonstrating that ALS extends beyond the
motor system. These results resonate well with previous
findings using voxel-based morphometry [11-13,40-42].
The current analysis of cortical thickness also pointed to
an involvement of additional extramotor areas including,
for example, the cingulate cortex, as well as regions in the
temporal and occipital cortex. That the CTA findings of
Table 2 Regions of reduced cortical thickness in ALS compared to control participants
Location # vertices Central vertex BV X BV Y BV Z BA
LH precentral G 51 30255 156.2 70.2 155.4 4
LH precentral G 132 7509 142.8 91.4 169.1 4
LH precentral G 24 7961 137.1 104.4 177.4 6
LH precentral S 23 30468 124.1 104.7 167.6 6
LH postcentral G 43 7932 141.8 98.5 176.7 1
LH postcentral G 17 27991 165.4 74.4 159.1 7
LH postcentral G 12 27754 169.4 82.3 159.5 7
LH postcentral G 21 8232 151.0 92.6 176.2 40
LH SPL 39 28075 186.2 80.2 152.2 7
LH IPL 17 19218 196.2 99.7 162.6 39
LH angular G 17 34659 178.3 92.8 169.3 39
LH angular G 27 33840 176.7 102.4 176.5 39
LH insula 12 12243 110.9 131.2 153.9 na
LH insula 12 779 119.3 134.5 158.6 na
LH insula 20 12358 124.7 133.1 162.5 na
LH supramarginal G 16 33153 160.9 106.5 172.6 40
LH uncus 13 38776 144.5 139.2 145.6 na
LH cingulate S 11 37338 98.8 128.6 133.4 11
LH cingulate S 14 40060 129.0 88.1 137.6 24
LH cingulate G 13 37611 96.7 116.0 134.5 24
LH cingulate G 17 25234 168.8 97.1 134.1 23
LH calcarine S 12 22417 186.8 127.0 151.0 17
RH precentral G 23 6950 166.0 64.9 122.5 4
RH precentral S 17 29332 136.2 80.8 100.8 4
RH postcentral G 19 1638 160.1 85.3 86.0 7
RH postcentral G 56 24668 152.6 94.7 78.2 40
RH inf. frontal S 15 37703 94.7 115.1 89.2 44
RH SPL 15 1788 183.9 76.5 103.2 7
RH lat. occipitotemp. G 16 21928 198.1 140.5 88.1 37
RH inf. temporal G 15 22236 196.8 132.1 83.1 20
RH sup. temporal S 14 21134 149.6 135.8 79.0 21
RH insula 31 5792 155.4 109.9 94.8 na
RH lateral S 19 6021 160.5 120.7 80.3 42
RH lateral S 11 25291 170.9 105.4 80.5 40
RH lateral S 14 23138 164.4 113.9 91.1 42
RH lateral S 67 39268 138.9 132.5 91.0 na
RH sup. frontal G 48 2234 95.3 99.8 120.4 8/9/10
RH cingulate G 11 11154 175.3 114.5 122.5 30
RH precuneus 21 17430 182.7 120.3 120.9 31
RH calcarine S 17 17781 185.8 125.9 104.8 17
RH med. occipitotemp. G 15 1082 197.2 131.8 118.9 19
RH med. occipitotemp. G 24 17728 178.6 135.0 105.4 19
RH lat. occipitotemp. G 45 16368 168.8 145.6 95.5 20/37
LH, RH: left, right hemisphere; size of the region is given as number of vertices, regions with 10 or less vertices are left out; the number of the central vertex and
its x,y,z coordinates as provided by Brain Voyager are also given; BA: Brodmann area; na: not available; G: gyrus; S: sulcus.
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Table 3 Regions of increased cortical thickness in ALS compared to control participants
Location # vertices Central vertex BV X BV Y BV Z BA
LH sup. temporal G 34 2693 129.7 137.9 177.8 38
LH med. temporal G 14 16528 147.6 143.4 186.0 20
LH inf. temporal G 22 14419 126.9 162.3 164.5 38
LH sup. frontal G 11 37020 81.9 89.2 135.0 9
LH SPL 19 27475 176.0 66.1 139.2 5
LH cingulate G 14 39937 118.3 98.4 133.0 24
LH cingulate G 23 25129 158.7 102.3 132.9 23
LH precuneus 17 21857 177.7 123.3 137.1 17
LH cingulate G 31 22280 167.9 129.8 140.3 30
LH hippocampus 39 13505 130.4 136.9 150.0 na
RH insula 12 38050 119.0 132.1 97.3 na
RH orbital G 20 34931 106.5 37.6 101.2 11
RH cingulate G 79 17828 170.9 128.0 116.6 30
LH, RH: left, right hemisphere; size of the region is given as number of vertices, regions with 10 or less vertices are left out; the number of the central vertex and
its x,y,z coordinates as provided by Brain Voyager are also given; BA: Brodmann area; na: not available; G: gyrus; S: sulcus.
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recent studies [28-30] as well as by reports of functional
changes implicating the same areas. For example, marked
alterations of early visual event-related potential compo-
nents [43] show that visual cortical areas are indeed al-
tered in the ALS disease process. Also, impaired initiation
and inhibition of movements implies the supplementary
motor area and right prefrontal cortex [8,44,45].
These findings could guide further neuropathological
investigations in ALS in order to pinpoint the underlyingFigure 2 Views of the left (upper part) and right (lower part) hemisph
reduced cortical thickness in ALS patients. See Figure 3 for results for sehistological changes. A marked loss of large pyramidal
cells and Betz cells in conjunction with astrocytic gliosis
has been described in motor cortex in ALS [25,46]. Other
neuropathological studies have shown loss of parvalbumin-
positive interneurons in ALS irrespective of the degree
of loss of Betz-cells in the motor cortex [47]. Loss of
GABAergic interneurons in the primary motor cortex
and beyond (dorsolateral prefrontal cortex and anterior
cingulate cortex) has also been documented [48]. According
to the present data extramotor involvement in ALS iseres with labels for the patches that showed significantly
lected patches.
Figure 3 Illustration of reduction of cortical thickness for
several patches in the pre- and postcentral gyri and the
precentral sulcus of both hemispheres. In each case, a reduction
of cortical thickness in ALS becomes apparent.
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ietal, temporal and occipital lobe. It remains to be seen
whether neuropathological changes are equivalent in all
of these regions. Also, it is important to note that the
patients involved in the current study were affected only
mildly or moderately. Application of cortical thickness
analysis in more advanced disease is therefore warranted.Figure 4 Relation of clinical severity and cortical thickness of
the right frontal gyrus. There was a negative correlation between
ALSFRS-R score and cortical thickness.A previous study using MRI-based cortical thickness
analysis in ALS used a region-of-interest approach rather
than a whole cortex analysis [27]. In contrast to the
present results, this study found a significant thinning
of the precentral but not postcentral gyrus in ALS. The
thickness of the precentral gyrus was determined to be
2.15 mm in normal controls which compares to about
2.8 mm found in neuropathological studies [26]. The
current data more closely resemble numbers usually found
in post-mortem studies. Another recent study investigated
primary lateral sclerosis and focussed on cortical thickness
of the primary motor cortex in the area of the hand-knob
[31]. Patients showed thinning of the motor cortex but
not of the primary sensory cortex. The present investiga-
tion as well as other recent studies [28-30] significantly
extends these previous findings by using a whole cortex
approach supplemented by regions of interest analysis.
Interestingly, cortical thickness in the right superior
frontal gyrus and in the right inferior frontal gyrus showed
a negative correlation with the ALSFRS-R score. This is
counter-intuitive, as lower ALSFRS-R scores indicate
worse clinical status and, thus, one would expect lower
scores to be associated with cortical thinning. It has to
be kept in mind, however, that the ALSFRS-R score
assesses global functionality of the patient with a strong
focus on motor functions and that the brain areas which
showed correlations in the present study were not primary
motor. In fact, we did not observe any correlations of the
ALSFRS-R score to cortical thickness in the precentral
gyrus. A recent study investigated cortical thickness and
used scores for upper motor neuron and lower motor
neuron involvement [31]. In this study, a regionally spe-
cific thinning (e.g., bulbar part of the motor cortex for
bulbar symptoms) was described in correlation with
upper motor neuron signs.
A few brain regions showed an increase of cortical
thickness in ALS, some of them even adjacent to regions
showing thinning. None of the VBM studies published
on ALS reported increases of grey matter density and it
is unclear whether such changes were assessed. While
the whole cortex statistics used in the present study were
properly safeguarded against type 1 error by correction for
multiple comparisons using cluster-size thresholding, it is
not impossible that one or the other brain area with in-
creased cortical thickness represents a “false positive”.
However, we do not believe that this can explain the
observed pattern. Interestingly, the areas with increased
thickness are located mainly in temporal and medial
frontal cortex (parts of the cingulate cortex). One pos-
sibility is that the observed increases are related to
compensatory mechanisms. For example, we have ob-
served an increase of cortical thickness in brain areas
related to visuospatial processing and memory in sub-
jects that did not learn to read (unpublished), which we
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visuospatial and memory processes. An interplay be-
tween frontal and temporal structures is often seen in
functional imaging studies of tasks involving executive
and working memory functions [49-52] and changes in
anatomical connectivity between frontal and temporal
structures have been documented in ALS [15]. More-
over, a pattern of hypo- and hyperactivation in a motor
task has been observed recently in relation to cortical
atrophy in ALS [53]. If structural loss (cortical thin-
ning) in one part of this system is related to structural
gain (cortical thickening) in the connected areas remains
to be tested in further studies.
Cortical thickness vs. voxel-based morphometry
This data set has been analyzed previously using VBM
[13] which had revealed widespread differences between
ALS and normal controls in areas including the right
(but not left) precentral gyrus, the postcentral gyrus bi-
laterally, the inferior parietal lobule bilaterally, and the
medial and superior frontal gyri bilaterally. Both, VBM
and CTA, showed a correlation between disease severity
as reflected by ALSFRS-R and the integrity of the right
frontal cortex. CTA appeared more sensitive than VBM
in the detection of involvement of extramotor areas.
Also, in contrast to the VBM-study the current analysis
revealed the left primary motor cortex and supplemen-
tary motor cortex. This suggests that cortical thickness
analysis is more sensitive to subtle changes of cortical
anatomy than VBM. Bermudez et al. [54] similarly reported
on differences between VBM and CTA in a study of ana-
tomical changes in professional musicians and underscored
the utility of CTA.
One further advantage of CTA is the fact that it mea-
sures a meaningful parameter, i.e. cortical thickness, that
readily compares to measurements obtained in neuro-
pathological specimens. The fact that the current mea-
surements (about 2.9 mm for the motor cortex in normal
participants) were almost identical to values obtained
using neuropathological methodology [26] is reassuring.
By contrast, VBM determines grey matter density and it is
unclear how this translates into actual anatomical changes
[54]. On the other hand, determination of cortical thick-
ness is considerably more time-consuming and requires
more user interaction than VBM which can be highly
automatized.
Limitations and prospects
Several limitations of the current study should be men-
tioned. First, the number of participants per group was
relatively small and thus the whole cortex analysis obvi-
ously is problematic. A larger data base of normal partic-
ipants and patients would be desirable. This could be
used to test the cortical thickness of individual patientsin selected regions of interest such as the pre- and
postcentral gyri against the distribution of the group, for
example using the test statistic proposed by Crawford
and Garthwaite [55]. Such an approach might prove
clinically useful in cases in which involvement of the
upper motor neuron is not yet apparent. To capture the
dynamics of the disease, longitudinal studies are desirable.
Recently, tools have been developed to assess changes of
cortical thickness over time [56].
Conclusions
The present study adds to previous investigations in
showing that the cortical involvement in ALS extends
considerably beyond the motor system. The task for the
future is to establish a relation between this involvement
and motor, cognitive, and emotional deficits in ALS. Ini-
tial steps in this direction have already been taken in a
recent publication [57].
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